Dupont Capital Management Corp Halozyme Therapeutics, Inc. Transaction History

Dupont Capital Management Corp

$1.18 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 25, 2023	SELL	$30.28 - $38.74 $7,600 - $9,723	-251 Reduced 10.23%	2,202 $79,000
Q1 2023 Apr 28, 2023	SELL	$32.86 - $55.7 $269,156 - $456,238	-8,191 Reduced 76.95%	2,453 $93,000
Q4 2022 Jan 26, 2023	BUY	$40.06 - $59.44 $15,302 - $22,706	382 Added 3.72%	10,644 $0
Q3 2022 Oct 31, 2022	SELL	$38.53 - $51.78 $130,462 - $175,327	-3,386 Reduced 24.81%	10,262 $406,000
Q2 2022 Jul 26, 2022	BUY	$37.35 - $48.3 $279,602 - $361,573	7,486 Added 121.49%	13,648 $601,000
Q1 2022 Apr 27, 2022	SELL	$31.97 - $41.06 $194,921 - $250,342	-6,097 Reduced 49.73%	6,162 $246,000
Q4 2021 Jan 31, 2022	SELL	$31.82 - $40.75 $154,454 - $197,800	-4,854 Reduced 28.36%	12,259 $493,000
Q3 2021 Nov 03, 2021	SELL	$38.47 - $46.42 $58,320 - $70,372	-1,516 Reduced 8.14%	17,113 $696,000
Q2 2021 Jul 30, 2021	SELL	$38.84 - $51.31 $793,773 - $1.05 Million	-20,437 Reduced 52.31%	18,629 $846,000
Q1 2021 Apr 29, 2021	BUY	$39.51 - $51.45 $185,776 - $241,917	4,702 Added 13.68%	39,066 $1.63 Million
Q4 2020 Jan 28, 2021	BUY	$25.81 - $43.62 $228,315 - $385,862	8,846 Added 34.67%	34,364 $1.47 Million
Q3 2020 Oct 29, 2020	SELL	$25.74 - $29.63 $309,729 - $356,537	-12,033 Reduced 32.04%	25,518 $671,000
Q2 2020 Jul 24, 2020	SELL	$16.25 - $26.81 $54,486 - $89,893	-3,353 Reduced 8.2%	37,551 $1.01 Million
Q4 2019 Jan 27, 2020	BUY	$14.93 - $19.53 $610,696 - $798,855	40,904 New	40,904 $725,000
Q1 2018 May 02, 2018	SELL	$17.06 - $21.2 $823,486 - $1.02 Million	-48,270 Closed	0 $0
Q3 2017 Oct 31, 2017	BUY	$11.76 - $17.4 $567,655 - $839,897	48,270	48,270 $838,000

Others Institutions Holding HALO

# of Institutions

543

Shares Held

125M

Call Options Held

294K

Put Options Held

180K

Black Rock Inc. New York, NY

17.6M
Shares

$838 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

12.9M
Shares

$613 Million
0.01% of portfolio
State Street Corp Boston, MA

6.63M
Shares

$315 Million
0.02% of portfolio
Snyder Capital Management L P San Francisco, CA

4.06M
Shares

$193 Million
5.07% of portfolio
Alliancebernstein L.P. New York, NY

3.41M
Shares

$162 Million
0.07% of portfolio

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.62B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Dupont Capital Management Corp with notifications on news.

Account